85 related articles for article (PubMed ID: 33759673)
1. Diagnostic and therapeutic challenges in hairy cell leukemia-variant: where are we in 2021?
Matutes E
Expert Rev Hematol; 2021 Apr; 14(4):355-363. PubMed ID: 33759673
[TBL] [Abstract][Full Text] [Related]
2. Mantle cell lymphoma - advances in molecular biology, prognostication and treatment approaches.
Silkenstedt E; Linton K; Dreyling M
Br J Haematol; 2021 Oct; 195(2):162-173. PubMed ID: 33783838
[TBL] [Abstract][Full Text] [Related]
3. Real-life targeted next-generation sequencing for lymphoma diagnosis over 1 year from the French Lymphoma Network.
Bommier C; Mauduit C; Fontaine J; Bourbon E; Sujobert P; Huet S; Baseggio L; Hayette S; Laurent C; Bachy E; Ghesquières H; Thieblemont C; Salles G; Traverse-Glehen A
Br J Haematol; 2021 Jun; 193(6):1110-1122. PubMed ID: 33764507
[TBL] [Abstract][Full Text] [Related]
4. The current role of interferon in hairy cell leukaemia: clinical and molecular aspects.
Assanto GM; Riemma C; Malaspina F; Perrone S; De Luca ML; Pucciarini A; Annechini G; D'Elia GM; Martelli M; Foà R; Tiacci E; Pulsoni A
Br J Haematol; 2021 Jul; 194(1):78-82. PubMed ID: 33932027
[TBL] [Abstract][Full Text] [Related]
5. Double-hit and triple-hit high-grade B-cell lymphoma of the ocular adnexa.
Henry RK; Bilyk JR; Evans JJ; Lao PA; Milman T
Orbit; 2022 Oct; 41(5):624-628. PubMed ID: 33779481
[TBL] [Abstract][Full Text] [Related]
6. MYC single-hit large B-cell lymphoma: clinicopathologic difference from MYC-negative large B-cell lymphoma and MYC double-hit/triple-hit lymphoma.
Cho YA; Hyeon J; Lee H; Cho J; Kim SJ; Kim WS; Ko YH
Hum Pathol; 2021 Jul; 113():9-19. PubMed ID: 33771538
[TBL] [Abstract][Full Text] [Related]
7. Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities.
Oben B; Froyen G; Maclachlan KH; Leongamornlert D; Abascal F; Zheng-Lin B; Yellapantula V; Derkach A; Geerdens E; Diamond BT; Arijs I; Maes B; Vanhees K; Hultcrantz M; Manasanch EE; Kazandjian D; Lesokhin A; Dogan A; Zhang Y; Mikulasova A; Walker B; Morgan G; Campbell PJ; Landgren O; Rummens JL; Bolli N; Maura F
Nat Commun; 2021 Mar; 12(1):1861. PubMed ID: 33767199
[TBL] [Abstract][Full Text] [Related]
8. Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia.
Tiacci E; De Carolis L; Simonetti E; Capponi M; Ambrosetti A; Lucia E; Antolino A; Pulsoni A; Ferrari S; Zinzani PL; Ascani S; Perriello VM; Rigacci L; Gaidano G; Della Seta R; Frattarelli N; Falcucci P; Foà R; Visani G; Zaja F; Falini B
N Engl J Med; 2021 May; 384(19):1810-1823. PubMed ID: 33979489
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukemia and COVID-19 adaptation of treatment guidelines.
Grever M; Andritsos L; Banerji V; Barrientos JC; Bhat S; Blachly JS; Call T; Cross M; Dearden C; Demeter J; Dietrich S; Falini B; Forconi F; Gladstone DE; Gozzetti A; Iyengar S; Johnston JB; Juliusson G; Kraut E; Kreitman RJ; Lauria F; Lozanski G; Parikh SA; Park J; Polliack A; Ravandi F; Robak T; Rogers KA; Saven A; Seymour JF; Tadmor T; Tallman MS; Tam CS; Tiacci E; Troussard X; Zent C; Zenz T; Zinzani PL; Wörmann B
Leukemia; 2021 Jul; 35(7):1864-1872. PubMed ID: 33947938
[TBL] [Abstract][Full Text] [Related]
10. Identification of genes associated with Kikuchi-Fujimoto disease using RNA and exome sequencing.
Anuntakarun S; Larbcharoensub N; Payungporn S; Reamtong O
Mol Cell Probes; 2021 Jun; 57():101728. PubMed ID: 33819568
[TBL] [Abstract][Full Text] [Related]
11. The Contemporary Approach to CALR-Positive Myeloproliferative Neoplasms.
Belčič Mikič T; Pajič T; Zver S; Sever M
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33806036
[No Abstract] [Full Text] [Related]
12. A New Anti-Estrogen Discovery Platform Identifies FDA-Approved Imidazole Anti-Fungal Drugs as Bioactive Compounds against ERα Expressing Breast Cancer Cells.
Cipolletti M; Bartoloni S; Busonero C; Parente M; Leone S; Acconcia F
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805656
[TBL] [Abstract][Full Text] [Related]
13. SMARCB1/INI1-deficient tumors of adulthood.
Parker NA; Al-Obaidi A; Deutsch JM
F1000Res; 2020; 9():662. PubMed ID: 33796273
[TBL] [Abstract][Full Text] [Related]
14. Erlotinib Activates Different Cell Death Pathways in EGFR-mutant Lung Cancer Cells Grown in 3D
Lee HK; Noh MH; Hong SW; Kim SM; Kim SH; Kim YS; Broaddus VC; Hur DY
Anticancer Res; 2021 Mar; 41(3):1261-1269. PubMed ID: 33788717
[TBL] [Abstract][Full Text] [Related]
15. Acalabrutinib in treatment-naive chronic lymphocytic leukemia.
Byrd JC; Woyach JA; Furman RR; Martin P; O'Brien S; Brown JR; Stephens DM; Barrientos JC; Devereux S; Hillmen P; Pagel JM; Hamdy A; Izumi R; Patel P; Wang MH; Jain N; Wierda WG
Blood; 2021 Jun; 137(24):3327-3338. PubMed ID: 33786588
[TBL] [Abstract][Full Text] [Related]
16. KDM5 inhibition offers a novel therapeutic strategy for the treatment of KMT2D mutant lymphomas.
Heward J; Konali L; D'Avola A; Close K; Yeomans A; Philpott M; Dunford J; Rahim T; Al Seraihi AF; Wang J; Korfi K; Araf S; Iqbal S; Bewicke-Copley F; Kumar E; Barisic D; Calaminici M; Clear A; Gribben J; Johnson P; Neve R; Cutillas P; Okosun J; Oppermann U; Melnick A; Packham G; Fitzgibbon J
Blood; 2021 Aug; 138(5):370-381. PubMed ID: 33786580
[TBL] [Abstract][Full Text] [Related]
17. Revisiting Richter transformation in the era of novel CLL agents.
Petrackova A; Turcsanyi P; Papajik T; Kriegova E
Blood Rev; 2021 Sep; 49():100824. PubMed ID: 33775465
[TBL] [Abstract][Full Text] [Related]
18. How can we assess and measure prognosis for MALT lymphoma? A review of current findings and strategies.
Kiesewetter B; Raderer M
Expert Rev Hematol; 2021 Apr; 14(4):391-399. PubMed ID: 33764848
[TBL] [Abstract][Full Text] [Related]
19. A novel anthraquinone‑quinazoline hybrid 7B blocks breast cancer metastasis and EMT via targeting EGFR and Rac1.
Kang J; Zhong Y; Tian W; Li J; Li X; Zhai L; Hou H; Li D
Int J Oncol; 2021 May; 58(5):. PubMed ID: 33760108
[TBL] [Abstract][Full Text] [Related]
20. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Maître E; Cornet E
Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
